SERAFINI, MARTA
SERAFINI, MARTA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
CARs are sharpening their weapons
2024 Pievani, A; Biondi, M; Tettamanti, S; Biondi, A; Dotti, G; Serafini, M
Defective IL-10-mediated modulation of monocytes from autoimmune patients
2024 Giacomello, G; Santoni De Sio, F; Forlani, A; Maioli, G; Scavini, M; Zanardini, A; Caporali, R; Piemonti, L; Serafini, M; Passerini and Silvia Gregori, L
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency
2024 Castiello, M; Brandas, C; Ferrari, S; Porcellini, S; Sacchetti, N; Canarutto, D; Draghici, E; Merelli, I; Barcella, M; Pelosi, G; Vavassori, V; Varesi, A; Jacob, A; Scala, S; Basso Ricci, L; Paulis, M; Strina, D; Di Verniere, M; Sergi Sergi, L; Serafini, M; Holland, S; Bergerson, J; De Ravin, S; Malech, H; Pala, F; Bosticardo, M; Brombin, C; Cugnata, F; Calzoni, E; Crooks, G; Notarangelo, L; Genovese, P; Naldini, L; Villa, A
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells
2024 Donsante, S; Pievani, A; Palmisano, B; Finamore, M; Fazio, G; Corsi, A; Biondi, A; Tomatsu, S; Piazza, R; Serafini, M; Riminucci, M
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies
2023 Tomasoni, C; Pievani, A; Rambaldi, B; Biondi, A; Serafini, M
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche
2023 Arsuffi, C; Biondi, A; Tettamanti, S; Serafini, M
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling
2023 Tomasoni, C; Arsuffi, C; Donsante, S; Corsi, A; Riminucci, M; Biondi, A; Pievani, A; Serafini, M
An in vivo humanized model to study homing and sequestration of Plasmodium falciparum transmission stages in the bone marrow.
2023 Donsante, S; Siciliano, G; Ciardo, M; Palmisano, B; Messina, V; de Turris, V; Farinacci, G; Serafini, M; Silvestrini, F; Corsi, A; Riminucci, M; Alano, P
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
2023 Alberti, G; Arsuffi, C; Pievani, A; Salerno, D; Mantegazza, F; Dazzi, F; Biondi, A; Tettamanti, S; Serafini, M
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML
2023 Perriello, V; Rotiroti, M; Pisani, I; Galimberti, S; Alberti, G; Pianigiani, G; Ciaurro, V; Marra, A; Sabino, M; Tini, V; Spinozzi, G; Mezzasoma, F; Morena, F; Martino, S; Salerno, D; Ashby, J; Wingham, B; Serafini, M; Martelli, M; Falini, B; Biondi, A; Tettamanti, S
Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling
2023 Doffini, A; Forcato, C; Mangano, C; Lattuada, D; Aversa, R; Maranta, C; Giovannone, E; Buson, G; Bolognesi, C; Maiocchi, R; Dori, M; Jamal, L; Ahmad, R; Yeo, G; Yeo, T; Saragozza, S; Silipigni, R; Serafini, M; Biondi, A; Perego, S; Vergani, P; Ferrazzi, E; Ricciardi-Castagnoli, P; Musci, T; Grati, F
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden
2023 Biondi, M; Tettamanti, S; Galimberti, S; Cerina, B; Tomasoni, C; Dotti, G; Biondi, A; Pievani, A; Serafini, M
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden
2023 Biondi, M; Tettamanti, S; Galimberti, S; Cerina, B; Tomasoni, C; Piazza, R; Donsante, S; Bido, S; Maria Perriello, V; Broccoli, V; Doni, A; Dazzi, F; Mantovani, A; Dotti, G; Biondi, A; Pievani, A; Serafini, M
Catch me if you can: how AML and its niche escape immunotherapy
2022 Tettamanti, S; Pievani, A; Biondi, A; Dotti, G; Serafini, M
CD14 positive cells accelerate hematopoietic stem cell engraftment
2022 Pievani, A; Granata, V; Desantis, G; Antolini, L; Ornaghi, S; Galleu, A; Biondi, A; Gentner, B; Dazzi, F; Serafini, M
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells
2022 Palmisano, B; Labella, R; Donsante, S; Remoli, C; Spica, E; Coletta, I; Farinacci, G; Dello Spedale Venti, M; Saggio, I; Serafini, M; Robey, P; Corsi, A; Riminucci, M
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M